These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17438515)

  • 21. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
    Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
    Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Need for research on estrogen receptor function: importance for postmenopausal hormone therapy and atherosclerosis.
    Meyer MR; Haas E; Barton M
    Gend Med; 2008; 5 Suppl A():S19-33. PubMed ID: 18395680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
    Dubey RK; Imthurn B; Barton M; Jackson EK
    Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative hormone replacement regimens: is there a need for further clinical trials?
    Welty FK
    Curr Opin Lipidol; 2003 Dec; 14(6):585-91. PubMed ID: 14624135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From the Women's Health Initiative to the combination of estrogen and selective estrogen receptor modulators to avoid progestin addition.
    Valera MC; Gourdy P; Trémollières F; Arnal JF
    Maturitas; 2015 Nov; 82(3):274-7. PubMed ID: 26261036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormone replacement therapy of menopause, heart and blood vessels].
    Kuttenn F; Gerson M
    Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of oestrogens and progestogens on coronary atherosclerosis and osteoporosis of monkeys.
    Adams MR; Williams JK; Clarkson TB; Jayo MJ
    Baillieres Clin Obstet Gynaecol; 1991 Dec; 5(4):915-34. PubMed ID: 1822826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials.
    Wild RA; Wu C; Curb JD; Martin LW; Phillips L; Stefanick M; Trevisan M; Manson JE
    Menopause; 2013 Mar; 20(3):254-60. PubMed ID: 23435021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
    Bhavnani BR
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial.
    Mack WJ; Hameed AB; Xiang M; Roy S; Slater CC; Stanczyk FZ; Lobo RA; Liu CR; Liu CH; Hodis HN
    Atherosclerosis; 2003 May; 168(1):91-8. PubMed ID: 12732391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
    Prentice RL; Manson JE; Langer RD; Anderson GL; Pettinger M; Jackson RD; Johnson KC; Kuller LH; Lane DS; Wactawski-Wende J; Brzyski R; Allison M; Ockene J; Sarto G; Rossouw JE
    Am J Epidemiol; 2009 Jul; 170(1):12-23. PubMed ID: 19468079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease, menopause and the impact of the estrogenic environment.
    Pines A
    Climacteric; 2016 Oct; 19(5):430-2. PubMed ID: 27327261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol and atherosclerosis: modulation by oestrogen.
    Barton M
    Curr Opin Lipidol; 2013 Jun; 24(3):214-20. PubMed ID: 23594711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of bazedoxifene, conjugated equine estrogens, and a tissue-selective estrogen complex containing both bazedoxifene and conjugated equine estrogens on cerebral artery atherosclerosis in postmenopausal monkeys.
    Clarkson TB; Ethun KF; Pajewski NM; Golden D; Floyd E; Appt SE
    Menopause; 2014 Jan; 21(1):8-14. PubMed ID: 23676638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.